Brief: Novabay Pharmaceuticals CEO Issues Letter To Stockholders
18/11/2021 12:31
Nov 18 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY PHARMACEUTICALS CEO ISSUES LETTER TO STOCKHOLDERS
Source text for Eikon: ID:nBw84x5Gza
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing